Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -235,757 | -124,428 | -81,862 | -38,046 | -151,085 |
| Depreciation Amortization | 942 | 712 | 476 | 240 | 810 |
| Income taxes - deferred | 2,653 | 2,255 | 1,001 | 434 | -26,529 |
| Accounts payable and accrued liabilities | -4,585 | -4,728 | -6,434 | -4,250 | -2,722 |
| Other Working Capital | 22,164 | -3,012 | -15,046 | -9,168 | -18,830 |
| Other Operating Activity | 72,528 | 29,946 | 23,999 | 13,504 | 38,014 |
| Operating Cash Flow | $-142,055 | $-99,255 | $-77,866 | $-37,286 | $-160,342 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,301 | 6,301 | -38,697 | 16,762 | -126,835 |
| PPE Investments | -34 | -34 | N/A | N/A | -169 |
| Investing Cash Flow | $31,267 | $6,267 | $-38,697 | $16,762 | $-127,004 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 109,335 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 370,832 | 365,520 | 118,567 | 10,493 | 21,117 |
| Other Financing Activity | -115,415 | -3,731 | -2,761 | 0 | 0 |
| Financing Cash Flow | $364,752 | $361,789 | $115,806 | $10,493 | $21,117 |
| Exchange Rate Effect | 1,227 | -1,805 | 99 | 219 | 615 |
| Beginning Cash Position | 128,030 | 128,030 | 128,030 | 128,030 | 393,644 |
| End Cash Position | 383,221 | 395,026 | 127,372 | 118,218 | 128,030 |
| Net Cash Flow | $255,191 | $266,996 | $-658 | $-9,812 | $-265,614 |
| Free Cash Flow | |||||
| Operating Cash Flow | -142,055 | -99,255 | -77,866 | -37,286 | -160,342 |
| Capital Expenditure | -34 | -34 | N/A | N/A | -169 |
| Free Cash Flow | -142,089 | -99,289 | -77,866 | -37,286 | -160,511 |